← Back to Search

Other

Enzalutamide or Abiraterone or Apalutamid for Prostate Cancer

Phase 1
Waitlist Available
Research Sponsored by Kangpu Biopharmaceuticals, Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to cycle-6 (28-day per cycle)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new drug called KPG-121, taken regularly, in adult subjects. The study aims to determine the safest dose and how well it works.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to cycle-6 (28-day per cycle)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to cycle-6 (28-day per cycle) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of KPG-121
Secondary study objectives
Incidence of Adverse Events [Safety and Tolerability]
Pharmacokinetic (PK) profile of KPG-121

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: KPG-121Experimental Treatment1 Intervention
Safety and Antitumor Activity of KPG-121 capsules at different dose level for 21 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enzalutamide or Abiraterone or Apalutamid
2019
Completed Phase 1
~20

Find a Location

Who is running the clinical trial?

Kangpu Biopharmaceuticals, Ltd.Lead Sponsor
3 Previous Clinical Trials
134 Total Patients Enrolled
Yao Wang, MDStudy DirectorKangpu Biopharmacuticals
YONG GUO, MDStudy DirectorKangpu Biopharmacuticals
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top